Article
Establishment of a human non-small cell lung cancer cell line resistant to gefitinib.
International journal of cancer - 10 Aug 2005
Koizumi Fumiaki, Shimoyama Tatsu, Taguchi Fumiko, Saijo Nagahiro, Nishio Kazuto
Abstract excerpt
The epidermal growth factor receptor (EGFR) tyrosine-kinase inhibitor gefitinib (Iressa, ZD1839) has shown promising activity preclinically and clinically. Because comparative investigations of drug-resistant sublines with their parental cells are useful approaches to identifying the mechanism of...
Topics
- Adaptor Proteins, Signal Transducing
- Carcinoma, Non-Small-Cell Lung
- Cell Line, Tumor
- Drug Resistance, Neoplasm
- GRB2 Adaptor Protein
- Gefitinib
- Genes, erbB-1
- Humans
- Intracellular Signaling Peptides and Proteins
- Lung Neoplasms
- Mutation
